Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913500
rs121913500
0.010 GeneticVariation BEFREE This study demonstrates that IDH1 R132H mutation with increased oncometabolite R-2HG in PCa cells may play important roles to increase PCa cell invasion. 31846689

2020

dbSNP: rs772893086
rs772893086
0.010 GeneticVariation BEFREE This study demonstrates that IDH1 R132H mutation with increased oncometabolite R-2HG in PCa cells may play important roles to increase PCa cell invasion. 31846689

2020

dbSNP: rs3181082
rs3181082
0.010 GeneticVariation BEFREE Our results indicated that <i>CD1B</i> rs3181082 confers prostate cancer progression and may help improve clinical prognostic stratification. 31783478

2019

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE This study demonstrated a significant association between the MSMB rs10993994 polymorphisms and PCa risk. 31773691

2019

dbSNP: rs2297441
rs2297441
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019

dbSNP: rs3208008
rs3208008
0.010 GeneticVariation BEFREE <i>RTEL1</i> rs2297441 [odds ratio (OR): 1.23; 95% confidence interval (CI): 1.03-1.46, <i>P</i> = 0.021] and rs3208008 (OR: 1.23; 95% CI: 1.03-1.46) were associated with PCa risk. 31762827

2019

dbSNP: rs4073
rs4073
0.050 GeneticVariation BEFREE The major findings of this meta-analysis suggested that IL-8 rs4073 polymorphism is significantly associated with risk of prostate cancer. 31718853

2019

dbSNP: rs486907
rs486907
0.100 GeneticVariation BEFREE CONCLUSIONS We report the effect of rs627928 on the development of prostate cancer and confirm that rs486907 is not involved in the risk of prostate cancer in the current meta-analysis. 31686670

2019

dbSNP: rs627928
rs627928
0.080 GeneticVariation BEFREE Nevertheless, rs627928 was reported to promote the development of prostate cancer (T vs. G: OR=1.08, 95% CI=1.01-1.15; TT+TG vs. GG: OR=1.14, 95% CI=1.03-1.25) in allele and recessive models in overall populations. 31686670

2019

dbSNP: rs145204276
rs145204276
0.020 GeneticVariation BEFREE We aimed to investigate the effect of variant rs145204276 of GAS5 on the prostate cancer susceptibility and clinicopathologic characteristics. 31673232

2019

dbSNP: rs851023
rs851023
0.010 GeneticVariation BEFREE The MAPK14 gene SNP rs851023 was associated with PCa and aggressive PCa risk after multiple comparison adjustment. 31667711

2019

dbSNP: rs13426236
rs13426236
0.010 GeneticVariation BEFREE This study provides strong evidence showing that prostate cancer risk SNP rs13426236 upregulates expression of MLPH transcript V4, which may function as a candidate oncogene in prostate cancer. 31659808

2020

dbSNP: rs662
rs662
0.020 GeneticVariation BEFREE <b>Conclusions:</b> We reported by the first time a correlation between rs662 (PON1) and PCa aggressiveness. 31647334

2019

dbSNP: rs35672330
rs35672330
0.010 GeneticVariation BEFREE We found two other EXO5 SNPs significantly associated with risk of PCa in cases-controls study from databases of genotype and phenotype (dbGaP), which are in linkage disequilibrium (D' = 1) with Exo5 L151P found in PCa family. 31616062

2020

dbSNP: rs919467999
rs919467999
ERG
0.010 GeneticVariation BEFREE We found two other EXO5 SNPs significantly associated with risk of PCa in cases-controls study from databases of genotype and phenotype (dbGaP), which are in linkage disequilibrium (D' = 1) with Exo5 L151P found in PCa family. 31616062

2020

dbSNP: rs1125927
rs1125927
0.010 GeneticVariation BEFREE We found 12 novel loci for PCa including rs1125927 (TMEM17, P = 3.95 × 10<sup>-16</sup>), rs73862213 (GATA2, P = 5.87 × 10<sup>-23</sup>), rs77911174 (ZMIZ1, P = 5.28 × 10<sup>-20</sup>), and rs138708 (SUN2, P = 1.13 × 10<sup>-15</sup>), seven of which had crucially low minor allele frequency in European population. 31562322

2019

dbSNP: rs138708
rs138708
0.010 GeneticVariation BEFREE We found 12 novel loci for PCa including rs1125927 (TMEM17, P = 3.95 × 10<sup>-16</sup>), rs73862213 (GATA2, P = 5.87 × 10<sup>-23</sup>), rs77911174 (ZMIZ1, P = 5.28 × 10<sup>-20</sup>), and rs138708 (SUN2, P = 1.13 × 10<sup>-15</sup>), seven of which had crucially low minor allele frequency in European population. 31562322

2019

dbSNP: rs73862213
rs73862213
0.010 GeneticVariation BEFREE We found 12 novel loci for PCa including rs1125927 (TMEM17, P = 3.95 × 10<sup>-16</sup>), rs73862213 (GATA2, P = 5.87 × 10<sup>-23</sup>), rs77911174 (ZMIZ1, P = 5.28 × 10<sup>-20</sup>), and rs138708 (SUN2, P = 1.13 × 10<sup>-15</sup>), seven of which had crucially low minor allele frequency in European population. 31562322

2019

dbSNP: rs77911174
rs77911174
0.010 GeneticVariation BEFREE We found 12 novel loci for PCa including rs1125927 (TMEM17, P = 3.95 × 10<sup>-16</sup>), rs73862213 (GATA2, P = 5.87 × 10<sup>-23</sup>), rs77911174 (ZMIZ1, P = 5.28 × 10<sup>-20</sup>), and rs138708 (SUN2, P = 1.13 × 10<sup>-15</sup>), seven of which had crucially low minor allele frequency in European population. 31562322

2019

dbSNP: rs854560
rs854560
0.020 GeneticVariation BEFREE Moreover, in the stratified analyses by cancer type, polymorphism of PON1-L55M played a risk factor in the occurrence of breast cancer, hematologic cancer, and prostate cancer. 31467900

2019

dbSNP: rs4588
rs4588
GC
0.020 GeneticVariation BEFREE When studies were stratified by cancer type, our results indicated that rs4588 significantly increased the risk of breast cancer and digestive system tumor, but not in prostate cancer and non-small cell lung cancer, while rs7041 significantly increased the risk of non-small cell lung cancer. 31467173

2019

dbSNP: rs4938723
rs4938723
0.020 GeneticVariation BEFREE Since miRNA-based mechanisms are shown to be involved in the pathogenesis of prostate cancer (PCa), the aim of the present study was to evaluate the effect of rs4938723, rs1076064 and rs4705343 occurring in regulatory regions of miR-34b/c, miR-143/145 and miR-378, respectively, on PCa risk and progression in Serbian population. 31423132

2019

dbSNP: rs1076064
rs1076064
0.010 GeneticVariation BEFREE Since miRNA-based mechanisms are shown to be involved in the pathogenesis of prostate cancer (PCa), the aim of the present study was to evaluate the effect of rs4938723, rs1076064 and rs4705343 occurring in regulatory regions of miR-34b/c, miR-143/145 and miR-378, respectively, on PCa risk and progression in Serbian population. 31423132

2019

dbSNP: rs4705343
rs4705343
0.010 GeneticVariation BEFREE Since miRNA-based mechanisms are shown to be involved in the pathogenesis of prostate cancer (PCa), the aim of the present study was to evaluate the effect of rs4938723, rs1076064 and rs4705343 occurring in regulatory regions of miR-34b/c, miR-143/145 and miR-378, respectively, on PCa risk and progression in Serbian population. 31423132

2019

dbSNP: rs1805794
rs1805794
NBN
0.040 GeneticVariation BEFREE Recently, it has been reported that the pathogenicity of this mutation with regard to prostate cancer risk is modified by a missense variant of the same gene (E185Q). 31410679

2019